 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/17/2024 |
$2.91 |
$2.94 |
$2.78 |
$2.78 |
710.50K | | 04/18/2024 |
$2.78 |
$2.80 |
$2.69 |
$2.73 |
1.02M | | 04/19/2024 |
$2.71 |
$2.81 |
$2.65 |
$2.72 |
931.50K | | 04/22/2024 |
$2.73 |
$2.77 |
$2.64 |
$2.64 |
740.40K | | 04/23/2024 |
$2.64 |
$2.75 |
$2.64 |
$2.75 |
1.09M |
|
|
| Arbutus Biopharma is a clinical-stage biopharmaceutical company utilizing its virology expertise to develop therapeutics that target specific viral diseases. Co.'s focus areas include Hepatitis B virus (HBV), SARS-CoV-2 and other coronaviruses. Co.'s product pipeline consists of the following programs: GalNAc RNAi, which is a subcutaneously-delivered RNA interference therapeutic targeted to hepatocytes; Oral Capsid Inhibitor, which is a capsid inhibitor; Oral PD-L1 Inhibitor, which is an oral PD-L1 inhibitor that has the potential to reawaken patients' HBV-specific immune response; and Oral HBV RNA Destabilizer, which is is Co.'s oral HBV specific RNA destabilizer. | |
|
Arbutus Biopharma (ABUS) has the following price history information. Looking back at ABUS historical stock prices for the last five trading days, on April 17, 2024, ABUS opened at $2.91, traded as high as $2.94 and as low as $2.78, and closed at $2.78. Trading volume was a total of 710.50K shares. On April 18, 2024, ABUS opened at $2.78, traded as high as $2.80 and as low as $2.69, and closed at $2.73. Trading volume was a total of 1.02M shares. On April 19, 2024, ABUS opened at $2.71, traded as high as $2.81 and as low as $2.65, and closed at $2.72. Trading volume was a total of 931.50K shares. On April 22, 2024, ABUS opened at $2.73, traded as high as $2.77 and as low as $2.64, and closed at $2.64. Trading volume was a total of 740.40K shares. On April 23, 2024, ABUS opened at $2.64, traded as high as $2.75 and as low as $2.64, and closed at $2.75. Trading volume was a total of 1.09M shares.
ABUS Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Arbutus Biopharma shares, starting with a $10,000 purchase of ABUS, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/25/2014 |
|
| End date: |
04/23/2024 |
|
| Start price/share: |
$13.89 |
|
| End price/share: |
$2.75 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-80.20% |
|
| Average Annual Total Return: |
-14.95% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$1,979.48 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/17/2024 | $2.78 | | 04/18/2024 | $2.73 | | 04/19/2024 | $2.72 | | 04/22/2024 | $2.64 | | 04/23/2024 | $2.75 |
|
|
